Elisa Placidi | Physics and Astronomy | Best Researcher Award

Dr. Elisa Placidi | Physics and Astronomy | Best Researcher Award

Fondazione Policlinico Universitario Agostino Gemelli IRCCS |Italy

Dr. Elisa Placidi is a distinguished researcher in medical physics and interventional radiotherapy, with a strong publication record reflected in 785 citations, an h-index of 16, and 26 i10-index publications. Her research focuses on advancing modern brachytherapy, improving dosimetric accuracy, and integrating innovative technologies such as 3D-printed applicators and image-guided systems. She has contributed extensively to studies evaluating the dosimetric impact of air gaps in high-dose-rate contact radiotherapy for non-melanoma skin cancers, the transition from PDR to HDR techniques for head and neck tumors, and the development of multilayer, high-density shielding applicators for personalized treatment. Her work also includes retrospective comparisons of HDR brachytherapy versus VMAT and electron beam therapy, investigations into patient-reported outcomes in nasal vestibule treatments, and characterization of plastic scintillator detectors for in vivo dosimetry. In her clinical role as a medical physicist, she supports treatment planning and optimization for external beam and interventional radiotherapy, contributing to high-precision cancer care. Complementing her clinical and research activities, she is involved in quality assurance and the academic training of future professionals in physics and radiological safety.

Profiles : Scopus | Orcid | Google Scholar

Featured Publications

Rosa, E., Fionda, B., Vaccaro, M., Placidi, E., Lancellotta, V., Napolitano, A., Pastore, F., Greco, F., Dragonetti, P., La Milia, M. C., et al. (2025). Dosimetric impact of air gaps in high-dose-rate contact interventional radiotherapy (modern brachytherapy) for non-melanoma skin cancer of the ear. Journal of Clinical Medicine, 14(21).

van Noortwijk, R., Kroon, P., Kastelijns, M., Jürgenliemk-Schulz, I., Verduijn, G., Kolkman-Deurloo, I.-K., Tagliaferri, L., Fionda, B., Placidi, E., Al-Mamgani, A., et al. (2025). A review on the transition from PDR to HDR brachytherapy (interventional radiotherapy) for treatment of head and neck cancer: Clinical and practical aspects. Brachytherapy.

Rosa, E., Raponi, S., Fionda, B., Vaccaro, M., Napolitano, A., Lancellotta, V., Pastore, F., Ciasca, G., Siebert, F.-A., Tagliaferri, L., et al. (2025). Intensity-modulated interventional radiotherapy using 3D-printed applicators with multilayer geometry and high-density shielding materials for NMSC treatment. Journal of Personalized Medicine, 15(10).

Rosa, E., Raponi, S., Fionda, B., Vaccaro, M., Lancellotta, V., Napolitano, A., Ciasca, G., Bannoni, L., Cornacchione, P., Tagliaferri, L., et al. (2025). 3D-printed devices in interventional radiotherapy (brachytherapy) applications: A literature review. Journal of Personalized Medicine, 15(6).

Tagliaferri, L., Manfrida, S., Fionda, B., Dinapoli, N., Barbaro, B., De Luca, V., Placidi, E., Bertolini, R., Marazzi, F., Lancellotta, V., et al. (2025). High-tailored anal canal radiotherapy (HIT-ART): Long-term results of MR image-guided interventional radiotherapy boost. Brachytherapy.

Placidi, E., Fionda, B., Rosa, E., Lancellotta, V., Napolitano, A., De Angeli, M., Ciasca, G., Pastore, F., Gambacorta, M. A., Tagliaferri, L., et al. (2024). Retrospective dosimetric comparison of HDR interventional radiotherapy versus planning with VMAT and electron beam therapy for non-melanoma skin cancer treatment. Applied Sciences, 14(22).

Tagliaferri, L., Sciurti, E., Fionda, B., Loperfido, A., Lancellotta, V., Placidi, E., Parrilla, C., La Milia, M. C., Rosa, E., Rigante, M., et al. (2024). PRO-NOVELTY: Patient-reported outcomes in nose vestibule interventional radiotherapy (brachytherapy). Journal of Clinical Medicine, 13(16).

Herreros, A., Pérez-Calatayud, J., Ballester, F., Abellana, R., Neves, J., Melo, J., Moutinho, L., Tarrats-Rosell, J., Serrano-Rueda, S., Tagliaferri, L., et al. (2024). Characterization of plastic scintillator detector for in vivo dosimetry in gynecologic brachytherapy. Journal of Personalized Medicine, 14(3).

Dong Hyun Kim | Medicine and Dentistry | Young Scientist Award

Dr. Dong Hyun Kim | Medicine and Dentistry | Young Scientist Award

Seoul National University College of Medicine | South Korea

Author Profile

Scopus

Orcid

Early Academic Pursuits 🎓

Dr. Dong Hyun Kim embarked on his medical journey at the prestigious Seoul National University College of Medicine, earning his Bachelor of Medicine in 2019. His academic rigor continued with a Master's degree in Medical Science, specializing in Translational Medicine, which he completed in 2024. His academic training laid the foundation for his future endeavors in clinical oncology and hematologic malignancies, blending medicine with cutting-edge research.

Professional Endeavors 🏥

Dr. Kim's professional career began at Seoul National University Hospital, where he completed his internship and then advanced to a Resident Doctor position in the Department of Internal Medicine. His expertise expanded into the field of Hemato-Oncology, where he currently serves as an External Clinical Researcher. His clinical work, especially in the realm of cancer treatment and translational medicine, has contributed significantly to patient care and scientific discovery.

Contributions and Research Focus 🔬

Dr. Kim’s research has made a considerable impact on hematologic malignancies and the use of artificial intelligence in oncology. His work spans various domains, including allogeneic stem cell transplantation, tumor-infiltrating lymphocytes as biomarkers, and predictive modeling in cancer treatment. Through his numerous publications, he has explored innovative treatments and personalized medicine, particularly focusing on improving patient outcomes in myelofibrosis, thymic epithelial neoplasms, and head and neck squamous cell carcinoma.

Accolades and Recognition 🏅

Dr. Kim has received numerous awards that underscore his contributions to the field. He earned the Best Oral Presentation Award at ICBMT 2022, a Presidential Oral Presentation at JSMO 2024, and another Best Oral Presentation Award at ICKSH 2024. These recognitions reflect his leadership in oncology research and his ability to present complex ideas with clarity and authority.

Impact and Influence 🌍

Through his published works, Dr. Kim has influenced the global oncology community. His research on artificial intelligence in oncology, predictive biomarkers, and innovative therapeutic approaches has opened new pathways in cancer treatment. His contributions, especially in improving treatment strategies for hematologic malignancies and solid tumors, are helping shape the future of personalized medicine.

Legacy and Future Contributions 🌟

Dr. Kim is poised to continue influencing the fields of clinical oncology and translational medicine. His dedication to research, combined with his clinical expertise, ensures that he will remain a key figure in advancing cancer treatment and improving patient outcomes. His future endeavors, backed by a solid academic and professional foundation, are expected to further elevate the standards of oncological care and research.

Publications


📄 Dual T-cell depletion with individually tailored anti-thymocyte globulin and attenuated dose of post-transplant cyclophosphamide in haploidentical peripheral stem cell transplantation
Author: Kim, D.H., Shin, D.-Y., Koh, Y., Byun, J.M., Hong, J.
Journal: Scientific Reports
Year: 2024


📄 Effects of tertiary palliative care on the pattern of end-of-life care in patients with hematologic malignancies in Korea
Author: Kim, D.H., Youk, J., Byun, J.M., Yoo, S.H., Shin, D.-Y.
Journal: European Journal of Haematology
Year: 2024


📄 Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study
Author: Kim, D.H., Lim, S.T., Kim, H.R., Shin, S.-H., Yun, H.J.
Journal: Oral Oncology
Year: 2024


📄 Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma
Author: Kim, D.H., Lim, Y., Ock, C.-Y., Kim, S.-B., Keam, B.
Journal: Head and Neck
Year: 2023